Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Impact of Progesterone on Stress Reactivity and Cannabis Use [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the impact of progesterone on stress reactivity and cannabis use completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cannabis Use | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28